Abstract:Objectives Lupus nephritis (LN) is a common and severe manifestation of SLE. Memory T (TM) cells have been implicated in the pathogenesis of SLE. This study aimed to investigate the clinical significance of T-cell subsets in a cohort of patients with LN. Method The peripheral blood T cells of 24 patients with LN and 13 patients with idiopathic membranous nephropathy (iMN) were analysed by flow cytometry. SLE disease activity was evaluated by SLE Disease Activity Index-2000 (SLEDAI-2K). Patients with LN were followed up for >6 months. Results Patients with LN presented lower frequency of CDC` cells and higher percentage of CD8(+) cells than patients with iMN, which was primarily due to lower CD4(+ )cell count. Interestingly, patients with LN under immunosuppressants had lower CD8(+)CD45R0 - TM frequency (p=0.007), fewer regulatory CD4(+) T cells (p=0.04) than those without immunosuppressants. Most CD4+ and CD8(+) TM cells in patients with LN showed an effector memory (C045RO(+)CCR7(+)) phenotype. The frequency of CD8(+)CD45R0(+) TM cells among the CD8(+) T cells was negatively correlated with white blood cell count, haemoglobin, platelet and serum levels of complements C3 and C4, but was positively correlated with serum IgG, erythrocyte sedimentation rate and SLEDAI score (p<0.05 each). Consistently, the frequency of CD8(+)CD45R0(+) TM cells was higher in patients with LN with positive antidouble-stranded DNA antibody, active renal disease, extrarenal manifestations and with sderotic glomeruli or moderate-to-severe mesangial hypercellularity in renal pathology (p<0.05). Additionally, CD8(+)CD45R0(+) TM cell frequency was significantly lower in patients with LN with renal complete remission than that in non-remission LN (18.7% vs 31.2%, p<0.05). None of these significant correlations was observed in CD4(+). TM cells. Conclusion The frequency of CD8(+) TM cells correlates with disease activity and treatment response to immunosuppressant in patients with LN. CD8(+) TM monitoring in patients with LN could provide more helpful indices for the monitoring and management of this disease.

Changes in the Expression of T-cell Factor-1 in Follicular Helper T Cells Reflect the Condition of Systemic Lupus Erythematosus Patients

Aberrant T Cell Subsets and Cytokines Expression Profile in Systemic Lupus Erythematosus.

Dysregulated T Cell Activation and Aberrant Cytokine Expression Profile in Systemic Lupus Erythematosus.

Pd-1(+)Cxcr5(-)Cd4(+)T Cells Are Correlated With The Severity Of Systemic Lupus Erythematosus

[Clinical Significance of CD4+CD25+ T Cells in Peripheral Blood of Patients in Systemic Lupus Erythematosus].

Aberrant CD200/CD200R1 Expression and Function in Systemic Lupus Erythematosus Contributes to Abnormal T-cell Responsiveness and Dendritic Cell Activity

Increased Circulating CD4+CXCR5+FoxP3+ Follicular Regulatory T Cells Correlated with Severity of Systemic Lupus Erythematosus Patients

Increased Interleukin 21 and Follicular Helper T-like Cells and Reduced Interleukin 10+ B Cells in Patients with New-onset Systemic Lupus Erythematosus

The Ratio of Circulating Follicular T Helper Cell to Follicular T Regulatory Cell is Correlated with Disease Activity in Systemic Lupus Erythematosus.

Aberrant expansion of follicular helper T cell subsets in patients with systemic lupus erythematosus

[Role of Circulating T Follicular Helper Subsets and T Follicular Helper Effector Memory Cells in Systemic Lupus Erythematosus].

T Follicular Helper Cells and Regulatory B Cells Dynamics in Systemic Lupus Erythematosus.

Activation of circulating TFH17 cells associated with activated naive and double negative 2 B cell expansion, and disease activity in systemic lupus erythematosus patients

The changes of CD4~+CD25~+ regulatory T cells and relevant cytokines in systemic lupus erythematosus patients

Peripheral blood T-cell subset and its clinical significance in lupus nephritis patients

[Altered Frequency of CD4+CD25-Foxp3+ T Cells in Patients with Systemic Lupus Erythematosus].

Increased CD4+CD25-Foxp3+ T Cells in Chinese Systemic Lupus Erythematosus: Correlate with Disease Activity and Organ Involvement.

Circulating TIGIT±PD1+TPH, TIGIT ± PD1+TFH cells are elevated and their predicting role in systemic lupus erythematosus

The Expression of Bcl-6 in Circulating Follicular Helper-Like T Cells Positively Correlates with the Disease Activity in Systemic Lupus Erythematosus.

Follicular Helper T Cells in Systemic Lupus Erythematosus: a Potential Therapeutic Target.

Associations of Circulating CXCR3–PD-1+CD4+T Cells with Disease Activity of Systemic Lupus Erythematosus